1,106 material Form 8-K filings that 909 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
HeartBeam said CEO Robert Eno agreed to leave as CEO and board member effective June 30, 2026, as part of a strategic reorganization. Founder and President Branislav Vajdic will become principal executive officer effective July 1, 2026, and the company said it will license its 3D ECG technology to established partners rather than rely only on direct medical device sales. Shareholders face a leadership transition and a change in business model, and the filing gives no financial results for the period.
Robert Eno's departure as CEO, board member and principal executive officer is effective June 30, 2026; he is expected to enter a consulting agreement.
Branislav Vajdic, Ph.D., becomes principal executive officer effective July 1, 2026; Rich Ferrari, Executive Chairman, co-leads the implementation teams.
Mark Strome resigned from the board and all committees effective immediately, as notified on June 18, 2026.
The company will provide more details on its strategy on its Second Quarter 2026 conference call in August.
Teradata entered a five-year, unsecured $400 million revolving credit agreement with Bank of America, N.A. as administrative agent, which replaces its 2022 credit agreement. The term loan outstanding under the prior agreement was repaid in full. The filing states the new facility matures June 24, 2031, and the company's prior agreement terms were substantially similar.
Five-year unsecured revolving facility of up to $400 million, maturing June 24, 2031, with possible extensions of up to two one-year periods by mutual agreement
Teradata may request up to $200 million of additional facility capacity, subject to lenders agreeing to provide it
Interest is floating, with margins of 1.000% to 1.500% for non-base-rate borrowings, based on Teradata's leverage ratio
Outstanding term loan under the 2022 Prior Agreement was repaid in full in connection with the new agreement
BellRing Brands approved workforce realignment actions to streamline operations, expecting annualized run-rate operating expense savings of about $10 to $12 million before taxes and one-time charges of about $6 million. Chief Growth Officer Douglas J. Cornille will step down effective June 24, 2026 and leave the company September 1, 2026.
Expected annualized run-rate operating expense savings of approximately $10 to $12 million before taxes, of which about $3 million is non-cash stock compensation
One-time workforce realignment charges estimated at approximately $6 million, mainly future cash severance costs, mostly in fiscal third quarter 2026
Savings expected to begin in fiscal fourth quarter 2026, with the majority in fiscal 2027
Douglas J. Cornille steps down as Chief Growth Officer effective June 24, 2026 and departs September 1, 2026
On June 23, 2026, Spring Valley Acquisition Corp. III issued an unsecured promissory note of up to $1.5 million to its sponsor, Spring Valley Acquisition Sponsor III, LLC, a significant shareholder, which can be drawn down from time to time. The note bears no interest and is payable when the company completes its initial business combination, and the sponsor may convert principal into warrants at $0.90 per warrant. The filing is for Spring Valley Acquisition Corp. III, not General Fusion Group Ltd. (GFUZ) as named in the request, so the ticker and company should be verified.
Note issued June 23, 2026 with principal of up to $1.5 million to Spring Valley Acquisition Sponsor III, LLC
No interest accrues; principal is payable on the date the company consummates its initial business combination
At maturity, the sponsor may convert principal into Working Capital Warrants at $0.90 per warrant
Filing names Spring Valley Acquisition Corp. III, not General Fusion Group Ltd. (GFUZ)
Gores Holdings XI, Inc., a blank check company, closed its initial public offering on June 24, 2026, selling 35,880,000 units at $10.00 each for gross proceeds of $358.8 million, including the underwriter's full exercise of its over-allotment option. The filing states that the full $358.8 million, including $10.8 million of deferred underwriter discount, was placed in a U.S.-based trust account, and that the funds generally cannot be released until a business combination is completed, shareholders vote on certain charter changes, or the company liquidates.
35,880,000 units sold at $10.00 per unit, including 4,680,000 over-allotment units, for gross proceeds of $358.8 million
$358.8 million placed in a trust account maintained by Equiniti Trust Company, LLC
Sponsor Gores Sponsor XI LLC bought 225,000 private placement Class A ordinary shares for about $2.25 million
Units began trading on Nasdaq as GHXIU on June 23, 2026; Randall Bort, Keith Covington and Elizabeth Marcellino joined the board
GitLab said its Chief Legal Officer, Head of Corporate Affairs and Corporate Secretary, Robin Schulman, will resign effective June 30, 2026, and that the decision was not due to any disagreement with the company. At the June 17, 2026 annual meeting, stockholders re-elected Karen Blasing and Godfrey Sullivan as Class II directors, ratified KPMG LLP as auditor for the fiscal year ending January 31, 2027, and approved executive compensation on a non-binding advisory basis.
Robin Schulman resigns as Chief Legal Officer, Head of Corporate Affairs and Corporate Secretary effective June 30, 2026; she notified the company on June 18, 2026.
Karen Blasing received 243,319,905 votes for and 1,622,441 withheld; Godfrey Sullivan received 221,171,373 for and 23,770,973 withheld. Both terms run to the 2029 annual meeting.
KPMG LLP ratification: 271,236,365 for and 4,277,434 against.
Advisory say-on-pay vote: 235,289,523 for and 8,873,423 against, with 779,400 abstaining.
Yorkville International Capital Corp., a blank-check company, closed its initial public offering of 23,000,000 units at $10.00 per unit on June 17, 2026, generating $230,000,000 in gross proceeds. The full $230,000,000 was placed in a trust account, and the company has not yet selected a business combination target. Shareholders' money stays in the trust until a business combination is completed or the shares are redeemed, with a 24-month completion window.
23,000,000 units sold at $10.00 each, including 3,000,000 units from the full exercise of the underwriters' over-allotment option, closed June 17, 2026.
$230,000,000 placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company.
Sponsor and Cohen & Company Capital Markets bought 6,300,000 private placement warrants at $1.00 each, for $6,300,000 in gross proceeds.
The company has not selected a target, and it has 24 months from the IPO closing to complete a business combination.
Texas Ventures Acquisition IV Corp, a blank check company, closed its initial public offering of 17,250,000 units at $10.00 per unit on June 22, 2026, including full exercise of the over-allotment option, for gross proceeds of $172,500,000. Of the proceeds and private placement, $173,362,500 was placed in a trust account, to be released only upon a business combination, certain shareholder votes, or redemption if no combination is completed within 18 months.
17,250,000 units sold at $10.00 each, for gross proceeds of $172,500,000 on June 22, 2026
$173,362,500, or $10.05 per unit, placed in trust; funds stay there until a business combination or redemption
Private placement of 6,100,000 warrants at $1.00 each ($6,100,000) to the Sponsor and Cohen & Company Capital Markets
Company has 18 months from the IPO closing to complete an initial business combination
Ingevity appointed Ryan Cotterman as Vice President, Chief Accounting Officer and principal accounting officer on June 22, 2026. He previously served as Senior Director, Corporate Controller at Ralliant Corporation and held controller and audit roles at Cornerstone Building Brands and Advance Auto Parts. The filing describes a routine finance leadership appointment with a disclosed compensation package.
Base salary of $345,000, bonus target of 40% of base salary, and long-term incentive opportunity of 65% of base salary starting in 2027
One-time sign-on cash bonus of $40,000 and restricted stock units with a grant date target value of $150,000, vesting over three years
Cotterman previously spent 14 years at Ernst & Young LLP and is a licensed Certified Public Accountant in North Carolina
On June 24, 2026, Resideo Funding Inc. merged into its wholly-owned subsidiary Resideo Funding II LLC, which assumed the company's 2029 and 2032 senior notes and its obligations under the June 4, 2026 credit agreement. Funding II also granted lenders a security interest in substantially all of its assets and agreed to guarantee company obligations under the credit agreement. Separately, on June 22, 2026, Resideo agreed with Honeywell to end a 2018 spin-off tax agreement in exchange for a one-time $11.6 million payment, which the filing describes as resolving tax-related claims between the two companies.
June 24, 2026: Resideo Funding Inc. merged into Resideo Funding II LLC, which continues as the surviving entity.
Funding II assumed the 4.000% Senior Notes due 2029 and 6.500% Senior Notes due 2032.
Funding II granted a security interest in substantially all its assets and guarantees company obligations under the credit agreement with JPMorgan Chase Bank, N.A. as administrative agent.
June 22, 2026: Tax Matters Agreement with Honeywell terminated; Resideo must pay a one-time $11,600,000 and both parties exchanged mutual releases.
At its June 23, 2026 annual meeting, CarMax shareholders approved an amended and restated 2002 Stock Incentive Plan that adds 1,842,000 shares for equity awards and extends the plan's termination date to June 23, 2036. Shareholders also re-elected the 11 director nominees, ratified KPMG LLP as auditor for fiscal 2027, and approved the advisory pay resolution for named executive officers.
Plan amendment adds 1,842,000 shares, adds a minimum vesting requirement with limited exceptions, bars dividend payments on unvested incentive awards, and extends the termination date from June 27, 2033 to June 23, 2036.
Plan approval vote: 109,927,642 for, 3,724,815 against, 1,666,088 abstaining.
Advisory say-on-pay vote: 107,869,976 for, 5,685,835 against, 1,762,734 abstaining.
KPMG LLP ratified as independent registered public accounting firm for fiscal year 2027 with 124,402,598 votes for and 1,969,402 against.
Absci Corporation agreed to sell 13,495,277 common shares at $7.41 each, with gross proceeds expected to be about $100 million and estimated net proceeds of about $93.5 million. The company plans to use the money to advance ABS-201 for androgenetic alopecia and endometriosis and for working capital and general corporate purposes, and the offering is expected to close on June 25, 2026. The sale adds new shares outstanding, which dilutes existing holders, and Eli Lilly & Company is among the participating investors.
13,495,277 shares priced at $7.41 per share, with gross proceeds of about $100 million
Estimated net proceeds of about $93.5 million after underwriting discounts and offering expenses
Proceeds earmarked for ABS-201 in androgenetic alopecia and endometriosis, plus working capital
Expected closing on or about June 25, 2026; sold under an S-3 shelf effective August 22, 2025
RBC Bearings entered into a new amended and restated employment agreement with CEO Michael Hartnett and an amendment to COO Daniel Bergeron's 2024 agreement, both dated June 23, 2026. The filing changes how equity awards are sized, using the average closing stock price over the six months before the 10-K filing, and aligns ROIC definitions with the company's historical practice.
Hartnett's base salary rises 3.0% to $1,591,350 per year, retroactive to June 1, 2026.
Bergeron's base salary rises 3.0% to $713,482, effective June 1, 2026.
Hartnett's new agreement has an initial term ending March 31, 2027, with automatic annual renewals unless either party gives 90 days' notice.
Equity awards for both executives will be sized on the six-month average closing price before the 10-K filing, rather than the award-date closing price.
Hoyne Bancorp's Audit Committee dismissed Wipfli LLP as its independent registered public accounting firm on June 22, 2026, effective immediately, and approved Plante & Moran, PLLC as the new auditor for the fiscal year ending December 31, 2026. The filing states Wipfli's audit reports for 2024 and 2025 contained no adverse or disclaimer opinion and were not qualified, and reports no disagreements with Wipfli; it also notes a material weakness disclosed in the 2025 Form 10-K that management says was remediated as of March 26, 2026. An auditor change is an administrative matter, but shareholders may want to note the prior material weakness.
Audit Committee dismissed Wipfli LLP on June 22, 2026, effective immediately
Plante & Moran, PLLC approved as new auditor for fiscal year ending December 31, 2026, subject to client acceptance procedures and an engagement letter
Wipfli's reports on 2024 and 2025 statements had no adverse or disclaimer opinion and were not qualified
Management determined a material weakness disclosed in the 2025 Form 10-K was remediated as of March 26, 2026
CubeSmart and its operating partnership entered a Third Amended and Restated Credit Agreement with Wells Fargo as agent, replacing an $850 million unsecured revolver with a $1 billion unsecured revolver maturing June 24, 2030. Initial advances repaid all amounts drawn under the prior facility, and the company says pricing depends on its credit ratings and leverage.
New unsecured revolving facility totals $1 billion, up from $850 million as of June 23, 2026
Facility matures June 24, 2030
Drawn amounts priced at 0.775% over SOFR plus a 0.15% facility fee at current ratings and leverage, with no SOFR floor
Initial advances repaid all amounts drawn under the prior credit facility
Sportsman's Warehouse Holdings entered into amended credit agreements on June 18, 2026, extending the maturity of its $45.0 million term loan to June 18, 2031, and reducing its senior secured revolving credit facility from $350 million to $315 million, with the same June 18, 2031 maturity. The filing states the new pricing ranges but does not compare them with the prior terms, and the company's obligations under both facilities remain secured by substantially all of its working capital assets and guaranteed by the company.
Term loan of $45.0 million: maturity extended to June 18, 2031; applicable margin of 4.00% or 7.00% plus a 0.10% SOFR adjustment, depending on loan type
Revolving line of credit commitment reduced from $350 million to $315 million, maturing June 18, 2031
Term Loan Agreement and Credit and Security Agreement Amendment filed as Exhibits 10.1 and 10.2
Wilco 63 Corp closed its initial public offering on June 22, 2026, selling 23,000,000 units at $10.00 each for gross proceeds of $230 million, including 3,000,000 units from the underwriters' over-allotment option. The company is a blank check company with no business combination yet, and all $230 million was placed in a trust account that stays restricted until a business combination or a redemption within 24 months of the IPO closing.
IPO closed June 22, 2026: 23,000,000 units at $10.00 per unit, $230,000,000 gross proceeds
Concurrent private placement of 5,000,000 warrants at $1.00 each, or $5,000,000; Sponsor bought 3,000,000 and Cantor Fitzgerald & Co. bought 2,000,000
$230,000,000 placed in trust; funds not released until a business combination or redemption if none is completed within 24 months
James Reynolds, Sriram Ramanathan, Matt Swann and Joseph Bradley were appointed independent directors on June 17, 2026; Reynolds chairs the Audit Committee
On June 24, 2026, Mercury General entered a Second Amended and Restated Credit Agreement with Bank of America, N.A. as administrative agent, providing a five-year, $250.0 million unsecured revolving facility that replaces its March 31, 2021 credit agreement. Borrowing costs depend on the company's Debt to Capital Ratio, and the agreement sets quarterly financial covenants that shareholders can track.
$250.0 million unsecured revolving facility matures June 24, 2031; proceeds may be used for general corporate purposes
Replaces the Amended and Restated Credit Agreement dated March 31, 2021
Term SOFR loans priced at 1.00% to 1.50% over the margin, Base Rate loans at 0.00% to 0.50%, and unused commitment fee of 0.10% to 0.225%, all based on the Debt to Capital Ratio
Quarterly covenants: shareholders' equity of at least $1,550.0 million plus 25% of positive annual net income, Debt to Capital Ratio no higher than 35%, and insurance subsidiary risk-based capital ratio of at least 150%
On June 18, 2026, Stanley Black & Decker entered a $1.0 billion 364-day revolving credit agreement and an amended five-year revolving credit agreement of $2.0 billion, replacing its prior 364-day facility dated June 23, 2025. No proceeds were drawn at closing, and the filing says the funds may be used for general corporate purposes.
364-Day Credit Agreement: $1.0 billion revolving loan, with repayment due by June 17, 2027 unless converted to a term loan.
Five Year Credit Agreement: $2.0 billion revolving loan, with maturity of June 18, 2031, subject to extension requests.
Both agreements require an interest coverage ratio of at least 3.50 to 1.00, relaxed to 2.50 to 1.00 through the second fiscal quarter of 2026.
The prior 364-day credit agreement dated June 23, 2025 was terminated in connection with the new facility.
On June 18, 2026, Crescent Capital BDC increased the dollar commitments under its SMBC revolving credit facility from $140 million to $165 million, and raised the maximum principal amount from $310 million to $335 million. The filing states that other terms of the facility were unchanged, so this is an expansion of existing borrowing capacity rather than a new loan.
Commitments under the SMBC Corporate Revolving Facility rose from $140 million to $165 million, effective June 18, 2026.
Maximum principal amount of the facility rose from $310 million to $335 million.
Sumitomo Mitsui Banking Corporation serves as administrative agent, collateral agent and lender.
All other terms of the facility remained unchanged, according to the filing.
At its June 18, 2026 annual meeting, Precigen stockholders approved an amendment adding 7 million shares to the 2023 Omnibus Incentive Plan for equity awards. The same meeting re-elected all nine directors, ratified Deloitte & Touche LLP as auditor for fiscal 2026, and approved the non-binding executive pay resolution, so the plan change is the only item that affects the share pool.
Plan amendment approved: 207,056,264 for, 4,996,260 against, 234,326 abstain, with 61,452,809 broker non-votes
All nine directors were elected to one-year terms, including Randal Kirk and Nancy Howell Agee
Deloitte & Touche LLP ratified as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 272,813,907 votes for
JPMorgan Chase released its 2026 Dodd-Frank Act stress test results on June 24, 2026, based on the Federal Reserve's hypothetical Supervisory Severely Adverse Scenario. The projections show the firm's common equity tier 1 (CET1) ratio falling from 14.6% at the end of 4Q25 to a projected minimum of 12.4%, ending at 14.4% in 1Q28, and $70.2 billion of projected loan losses over nine quarters. The company states that these are hypothetical estimates, not forecasts of actual results.
Projected minimum CET1 ratio of 12.4%, versus 14.6% actual at 4Q25 and a 4.5% regulatory minimum
Nine-quarter projected pre-provision net revenue of $135.9 billion and provision for credit losses of $95.6 billion (1Q26 to 1Q28)
Projected net income before taxes of $11.4 billion and total projected loan losses of $70.2 billion
JPMorgan Chase Bank, N.A. projected minimum CET1 ratio of 13.2%
Chewy entered a new seven-year senior secured term loan of $600.0 million on June 23, 2026, led by JPMorgan Chase Bank as administrative agent. The company also amended its ABL credit facility to extend the maturity date to June 23, 2031, giving it added borrowing capacity and debt terms that run further out.
Term loan of $600.0 million, maturing seven years after closing, with 1% annual amortization in quarterly installments
Term SOFR loans priced at a margin of 1.75%; base rate loans at 0.75%
Loan is guaranteed by wholly-owned domestic subsidiaries and secured by substantially all company assets
ABL facility maturity extended to June 23, 2031 under Amendment No. 4
Effective June 24, 2026, PIMCO Income Strategy Fund II (PFN) is permitted to invest in and/or originate loans as a principal investment strategy, as disclosed in a prospectus and SAI supplement filed as Exhibit 99.1. The supplement adds new risk disclosures covering loan origination, foreign loan originations, and loan participations, including possible subprime-quality loans and limited liquidity.
Effective date of the strategy change: June 24, 2026
Loans may include residential and commercial real estate or mortgage-related loans, consumer loans, and below investment grade borrowers
Fund is not limited in the amount, size or type of loans, other than by applicable law and its RIC qualification requirements
Filing adds risk disclosures on loan origination, foreign loan originations, and loan liquidity
Effective June 24, 2026, PIMCO Income Strategy Fund can invest in and/or originate loans as a principal investment strategy, according to a prospectus supplement filed with the 8-K. The supplement adds new risk disclosures, including loan origination and foreign loan origination risks, and states the fund may hold loans that are subprime in quality.
Change effective June 24, 2026; supplement dated June 24, 2026 amends the prospectus and statement of additional information dated February 13, 2024
Loans may include residential and commercial real estate or mortgage-related loans, consumer loans, and loans to borrowers rated below investment grade or unrated
The fund is not restricted by any particular borrower credit criteria and states some loans may be subprime in quality or become subprime
The fund may originate loans to foreign and emerging market entities and individuals, and may bear costs of originating loans whether or not they are completed
PIMCO Corporate & Income Opportunity Fund (PTY) said it may, as a principal investment strategy, invest in and/or originate loans effective June 24, 2026, and may invest without limitation in defaulted bonds effective July 24, 2026. The changes are set out in a prospectus and statement of additional information supplement dated June 24, 2026, and the filing describes added risks such as credit, liquidity and subprime loan exposure.
Loan investing and origination permitted as a principal strategy effective June 24, 2026
Investment in defaulted bonds without limitation effective July 24, 2026, subject to other investment policies
Supplement dated June 24, 2026 revises the prospectus and SAI dated September 28, 2023; new risk disclosures cover loan origination and foreign loans
PIMCO High Income Fund (PHK) said that, effective June 24, 2026, it may invest in and/or originate loans as a principal investment strategy, and that from July 24, 2026 it may invest without limitation in bank loans. The changes are set out in a prospectus and statement of additional information supplement dated June 24, 2026. The filing describes added risks, including credit, liquidity, and subprime borrower exposure, that shareholders would bear if the Fund expands into loans.
Loan investing and origination permitted as a principal strategy effective June 24, 2026
Unlimited investment in bank loans permitted effective July 24, 2026
Supplement to the prospectus and SAI dated June 24, 2026 filed as Exhibit 99.1
Filing adds risk disclosures on loan origination, foreign loan originations, and loan liquidity
PIMCO Corporate & Income Strategy Fund (PCN) disclosed a prospectus and statement of additional information supplement dated June 24, 2026. The Fund is now permitted, as a principal investment strategy, to invest in and/or originate loans, and effective July 24, 2026 it may invest without limitation in defaulted bonds, subject to its other investment policies. The changes expand the range of assets the Fund may hold, which can add credit, liquidity and valuation risks for shareholders.
Loan investing and origination permitted as a principal investment strategy, effective June 24, 2026
Unlimited investment in defaulted bonds permitted effective July 24, 2026, subject to other investment policies
Supplement also revises credit quality policy and adds loan origination and foreign loan origination risk disclosures
Changes are disclosed in Exhibit 99.1 to the filing
Effective July 24, 2026, PIMCO Strategic Income Fund may invest without limitation in commercial mortgage-related securities and may put up to 50% of total assets into debt rated below investment grade or unrated but deemed comparable by PIMCO. The change alters the fund's permitted investment scope, and shareholders will see it reflected in the annual shareholder report on Form N-CSR for the period ended June 30, 2026.
Effective date of the investment guideline change is July 24, 2026.
Commercial mortgage-related securities may be held without limitation.
Up to 50% of total assets may be invested in debt rated below Baa3 by Moody's or below BBB- by S&P or Fitch, or unrated but comparable in PIMCO's view.
Disclosure change will first appear in the N-CSR for the 12-month period ended June 30, 2026.
Effective July 24, 2026, the fund is permitted to invest without limitation in senior float-rate loans made to corporations, partnerships and other business entities. The change will appear in shareholder reports starting with the annual report on Form N-CSR for the 12-month period ended June 30, 2026.
Investment guideline change effective July 24, 2026
Fund may invest without limitation in senior float-rate loans to business entities
Change first reflected in N-CSR for the 12 months ended June 30, 2026
The Fund's Board of Trustees approved a change to the Fund's 80% investment policy on June 23, 2026. Starting August 28, 2026, the Fund will invest at least 80% of net assets in a global portfolio of equity and/or income-producing investments, a broader description than before. The filing is a policy change with no reported financial results or effect on fund figures.
Board of Trustees approved the policy change on June 23, 2026.
Effective date of the new policy is August 28, 2026.
The new policy covers at least 80% of net assets, plus any borrowings for investment purposes, in equity and/or income-producing investments.
Income-producing investments include fixed income instruments and dividend-paying equity securities, along with related derivatives.
The Fund's Board of Trustees approved changes to its 80% investment policy on June 23, 2026, effective August 28, 2026. The policy now covers corporate debt obligations and income-producing investments, which may include those of non-corporate issuers, and the filing describes which instruments count as income-producing.
Board approved the policy change on June 23, 2026; effective date is August 28, 2026.
Fund invests at least 80% of net assets (plus borrowings for investment purposes) in corporate debt obligations and/or income-producing investments.
Fund may not change the 80% Policy without at least 60 days' written notice to shareholders.
Supplement dated June 24, 2026 updates the prospectus and statement of additional information (Exhibit 99.1).
The Fund's Board of Trustees approved changes to the Fund's 80% investment policy on June 23, 2026, effective August 28, 2026. The revised policy lets the Fund count income-producing investments, including certain derivatives and dividend-paying equities, toward its 80% test, and allows non-corporate issuers. The filing discloses the change through a prospectus and SAI supplement and does not report any financial results.
Board of Trustees approved the change on June 23, 2026; effective date is August 28, 2026.
Fund invests at least 80% of net assets (plus borrowings for investment purposes) in corporate debt and/or income-producing investments, which may include non-corporate issuers.
Income-producing investments may include dividend-paying equity securities and derivatives on them, alongside Fixed Income Instruments.
The Fund may not change this 80% Policy without at least 60 days' written notice to shareholders.
At its June 18, 2026 Annual Meeting, PVH stockholders approved amendments to the company's Stock Incentive Plan. The amendments add 1,068,000 shares to the pool available for awards and raise the share-counting factor for full value awards granted on or after June 18, 2026 from 1.6 to 1.72 shares per share underlying the award. Because the change adds to the shares available for employee and director equity grants, it can dilute existing shareholders over time.
Stockholders approved adding 1,068,000 shares of common stock to the Plan's available pool
Full value awards granted on or after June 18, 2026 count as 1.72 shares, up from 1.6 shares
The Plan's total share authorization is 24,493,589 shares and the Plan terminates April 29, 2030
Director awards are capped at $750,000 in total value over any 12-month period
On June 22, 2026, CAVA's compensation committee amended and restated its Executive Severance Plan, limiting eligibility to Executive Leadership Team members and adding conditions such as a signed release, reduced severance pay, and a shorter post-change-in-control standstill period. At the same day's annual meeting, stockholders elected two Class III directors, approved executive pay on an advisory basis, and ratified Deloitte & Touche LLP as auditor for fiscal 2026.
Brett Schulman received 85,651,941 votes for and 882,410 withheld; James D. White received 63,427,817 for and 23,106,534 withheld.
Advisory say-on-pay vote: 75,849,587 for, 10,573,039 against, and 111,725 abstentions.
Severance benefits now require a Release and Restrictive Covenants Agreement submitted within 15 business days of a Covered Termination.
Base salary continuation is reduced dollar-for-dollar by compensation earned from any employer or contractor during the Severance Period; Deloitte ratification received 100,054,705 votes for and 378,617 against.
Massimo Group entered a loan agreement on June 23, 2026, under which it can borrow up to $4 million from David Shan, its Executive Chairman, over one year to fund strategic growth initiatives in security and mobility technology. The company also terminated its proposed acquisition of FST Development Company Limited, which had been disclosed on February 3, 2026, and could have been paid partly in company shares, so shareholders would not face that share issuance.
Loan of up to $4 million from David Shan, Executive Chairman, dated June 23, 2026
Interest rate of 4%, payable monthly, with principal and unpaid interest due June 22, 2027
Loan obligations are unsecured and include customary covenants and default provisions
Proposed FST Development Company Limited acquisition terminated; no longer pursuing stock-based structure
Freshpet said co-founder and President Scott Morris will retire effective October 20, 2026, and will serve as an advisor for 18 months afterward. Chief Operating Officer Nicola Baty will take on the additional role of President on the Separation Date.
Scott Morris retires effective October 20, 2026, and is paid base salary until then
Morris becomes an advisor for 18 months at bi-weekly gross payments of $38,904
Nicola Baty, COO since September 2024, will also become President on the Separation Date
Unvested RSUs vest at separation; PSUs vest pro rata through December 2026 subject to performance metrics
Molson Coors said Philip Whitehead, President and CEO of its EMEA&APAC business, is temporarily stepping away from his role due to a medical condition. Simon Kerry, Managing Director of the U.K. and Ireland regional business, will serve as interim Managing Director of EMEA&APAC during the leave. The filing gives no return date or financial figures, so the effect on shareholders is not quantified.
Philip Whitehead, President and CEO of EMEA&APAC, is temporarily stepping away due to a medical condition
Simon Kerry, Managing Director of U.K. and Ireland, named interim Managing Director of EMEA&APAC
Announced June 24, 2026; the filing does not state the length of the leave
Bionano Genomics said it has hired Alex Hastie, Ph.D., as Chief Scientific Officer, effective July 20, 2026. Dr. Hastie previously worked at the company for 14 years and helped develop its core optical genome mapping technologies, and he will lead the company's global scientific strategy and research initiatives. The filing gives no financial figures, and the appointment is an executive hire rather than a change in financial results.
Alex Hastie, Ph.D., appointed Chief Scientific Officer, effective July 20, 2026
Dr. Hastie previously spent 14 years at Bionano helping develop its core technologies
He will lead global scientific strategy, innovation roadmap and research initiatives
Announced by interim CEO and chairman Albert A. Luderer, Ph.D. in a June 24, 2026 press release
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.